Abstract
Summary
LPI (LP Information)' newest research report, the “Infectious Disease In-vitro Diagnostic Industry Forecast” looks at past sales and reviews total world Infectious Disease In-vitro Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Infectious Disease In-vitro Diagnostic sales for 2023 through 2029. With Infectious Disease In-vitro Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease In-vitro Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Infectious Disease In-vitro Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease In-vitro Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease In-vitro Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease In-vitro Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease In-vitro Diagnostic.
The global Infectious Disease In-vitro Diagnostic market size is projected to grow from US$ 55 million in 2022 to US$ 72 million in 2029; it is expected to grow at a CAGR of 4.0% from 2023 to 2029.
United States market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Infectious Disease In-vitro Diagnostic players cover BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease In-vitro Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Immunoassay
Molecular Diagnostics
Microbiology
Others
Segmentation by application
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
This Insight Report provides a comprehensive analysis of the global Infectious Disease In-vitro Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease In-vitro Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease In-vitro Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease In-vitro Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease In-vitro Diagnostic.
The global Infectious Disease In-vitro Diagnostic market size is projected to grow from US$ 55 million in 2022 to US$ 72 million in 2029; it is expected to grow at a CAGR of 4.0% from 2023 to 2029.
United States market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Infectious Disease In-vitro Diagnostic players cover BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease In-vitro Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Immunoassay
Molecular Diagnostics
Microbiology
Others
Segmentation by application
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size 2018-2029
2.1.2 Infectious Disease In-vitro Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Infectious Disease In-vitro Diagnostic Segment by Type
2.2.1 Immunoassay
2.2.2 Molecular Diagnostics
2.2.3 Microbiology
2.2.4 Others
2.3 Infectious Disease In-vitro Diagnostic Market Size by Type
2.3.1 Infectious Disease In-vitro Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023)
2.4 Infectious Disease In-vitro Diagnostic Segment by Application
2.4.1 COVID-19
2.4.2 MRSA
2.4.3 Clostridium Difficile
2.4.4 Respiratory Virus
2.4.5 TB and Drug-resistant TB
2.4.6 Chlamydia
2.4.7 Gonorrhea
2.4.8 HPV
2.4.9 HIV
2.4.10 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
2.5 Infectious Disease In-vitro Diagnostic Market Size by Application
2.5.1 Infectious Disease In-vitro Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023)
3 Infectious Disease In-vitro Diagnostic Market Size by Player
3.1 Infectious Disease In-vitro Diagnostic Market Size Market Share by Players
3.1.1 Global Infectious Disease In-vitro Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Infectious Disease In-vitro Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease In-vitro Diagnostic by Regions
4.1 Infectious Disease In-vitro Diagnostic Market Size by Regions (2018-2023)
4.2 Americas Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
4.3 APAC Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
4.4 Europe Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
5 Americas
5.1 Americas Infectious Disease In-vitro Diagnostic Market Size by Country (2018-2023)
5.2 Americas Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
5.3 Americas Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease In-vitro Diagnostic Market Size by Region (2018-2023)
6.2 APAC Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
6.3 APAC Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Disease In-vitro Diagnostic by Country (2018-2023)
7.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease In-vitro Diagnostic by Region (2018-2023)
8.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Infectious Disease In-vitro Diagnostic Market Forecast
10.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas Infectious Disease In-vitro Diagnostic Forecast
10.1.3 APAC Infectious Disease In-vitro Diagnostic Forecast
10.1.4 Europe Infectious Disease In-vitro Diagnostic Forecast
10.1.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast
10.2 Americas Infectious Disease In-vitro Diagnostic Forecast by Country (2024-2029)
10.2.1 United States Infectious Disease In-vitro Diagnostic Market Forecast
10.2.2 Canada Infectious Disease In-vitro Diagnostic Market Forecast
10.2.3 Mexico Infectious Disease In-vitro Diagnostic Market Forecast
10.2.4 Brazil Infectious Disease In-vitro Diagnostic Market Forecast
10.3 APAC Infectious Disease In-vitro Diagnostic Forecast by Region (2024-2029)
10.3.1 China Infectious Disease In-vitro Diagnostic Market Forecast
10.3.2 Japan Infectious Disease In-vitro Diagnostic Market Forecast
10.3.3 Korea Infectious Disease In-vitro Diagnostic Market Forecast
10.3.4 Southeast Asia Infectious Disease In-vitro Diagnostic Market Forecast
10.3.5 India Infectious Disease In-vitro Diagnostic Market Forecast
10.3.6 Australia Infectious Disease In-vitro Diagnostic Market Forecast
10.4 Europe Infectious Disease In-vitro Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany Infectious Disease In-vitro Diagnostic Market Forecast
10.4.2 France Infectious Disease In-vitro Diagnostic Market Forecast
10.4.3 UK Infectious Disease In-vitro Diagnostic Market Forecast
10.4.4 Italy Infectious Disease In-vitro Diagnostic Market Forecast
10.4.5 Russia Infectious Disease In-vitro Diagnostic Market Forecast
10.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt Infectious Disease In-vitro Diagnostic Market Forecast
10.5.2 South Africa Infectious Disease In-vitro Diagnostic Market Forecast
10.5.3 Israel Infectious Disease In-vitro Diagnostic Market Forecast
10.5.4 Turkey Infectious Disease In-vitro Diagnostic Market Forecast
10.5.5 GCC Countries Infectious Disease In-vitro Diagnostic Market Forecast
10.6 Global Infectious Disease In-vitro Diagnostic Forecast by Type (2024-2029)
10.7 Global Infectious Disease In-vitro Diagnostic Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Infectious Disease In-vitro Diagnostic Product Offered
11.1.3 BD Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioMérieux SA
11.2.1 BioMérieux SA Company Information
11.2.2 BioMérieux SA Infectious Disease In-vitro Diagnostic Product Offered
11.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BioMérieux SA Main Business Overview
11.2.5 BioMérieux SA Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Infectious Disease In-vitro Diagnostic Product Offered
11.3.3 Abbott Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Quidel Corporation
11.4.1 Quidel Corporation Company Information
11.4.2 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Offered
11.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Quidel Corporation Main Business Overview
11.4.5 Quidel Corporation Latest Developments
11.5 OraSure Technologies, Inc.
11.5.1 OraSure Technologies, Inc. Company Information
11.5.2 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Offered
11.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 OraSure Technologies, Inc. Main Business Overview
11.5.5 OraSure Technologies, Inc. Latest Developments
11.6 Hologic, Inc. (Gen Probe)
11.6.1 Hologic, Inc. (Gen Probe) Company Information
11.6.2 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Offered
11.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Hologic, Inc. (Gen Probe) Main Business Overview
11.6.5 Hologic, Inc. (Gen Probe) Latest Developments
11.7 Danaher
11.7.1 Danaher Company Information
11.7.2 Danaher Infectious Disease In-vitro Diagnostic Product Offered
11.7.3 Danaher Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Danaher Main Business Overview
11.7.5 Danaher Latest Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Information
11.8.2 QIAGEN Infectious Disease In-vitro Diagnostic Product Offered
11.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 QIAGEN Main Business Overview
11.8.5 QIAGEN Latest Developments
11.9 Roche
11.9.1 Roche Company Information
11.9.2 Roche Infectious Disease In-vitro Diagnostic Product Offered
11.9.3 Roche Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Roche Main Business Overview
11.9.5 Roche Latest Developments
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG Company Information
11.10.2 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Offered
11.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Siemens Healthineers AG Main Business Overview
11.10.5 Siemens Healthineers AG Latest Developments
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Information
11.11.2 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Offered
11.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.11.5 Bio-Rad Laboratories, Inc. Latest Developments
12 Research Findings and Conclusion